30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Vivos Therapeutics Inc (VVOS)

Track

Over the last 90 days, Vivos Therapeutics Inc. has seen three insider buy transactions totaling $2.23 million, all executed by Michael C. Skaff. No sell transactions were reported. The company's stock has experienced a significant decline of 57.5% in the past 90 days. The last reported earnings missed expectations by 25.3%.
Stock chart
Ticker: VVOS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Skaff Michael C
3 purchases — total 2,227,714 USD
Buy 31 Mar 2026
Value US$1,198,853.95 | Price 16.60 | Shares 10,820
Buy 31 Mar 2026
Value US$2,174,081.57 | Price 392.84 | Shares 33,408
Buy 31 Mar 2026
Value US$1,400,001.18 | Price 1.34 | Shares 1,044,777
Buy 20 Jun 2023
Value US$333,583.93 | Price 351.33 | Shares 89,122
Buy 16 Jun 2023
Value US$2,650.00 | Price 0.53 | Shares 5,000
Buy 16 Jun 2023
Value US$5,400.00 | Price 0.54 | Shares 10,000
Buy 15 Jun 2023
Value US$10.50 | Price 0.50 | Shares 21
Buy 14 Jun 2023
Value US$4,900.00 | Price 0.49 | Shares 10,000
Buy 23 Dec 2022
Value US$10,000.00 | Price 0.50 | Shares 20,000
Buy 1 Jun 2022
Value US$7,320.00 | Price 1.83 | Shares 4,000
Buy 31 May 2022
Value US$16,240.00 | Price 2.03 | Shares 8,000
Buy 25 May 2021
Value US$5,290.00 | Price 5.29 | Shares 1,000
Buy 25 May 2021
Value US$21,520.00 | Price 5.38 | Shares 4,000
Buy 24 Dec 2020
Value US$7,380.00 | Price 7.38 | Shares 1,000
Buy 23 Dec 2020
Value US$7,266.90 | Price 7.27 | Shares 1,000
Buy 11 Dec 2020
Value US$4,250.00 | Price 8.50 | Shares 500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-02 2026-03-31 B Purchase
Skaff Michael C
Large shareholder
10,820 -9.7%
16.60
US$1,198,854 		10,820 -9.7% 16.60 US$1,198,854
2026-04-02 2026-03-31 B Purchase
Skaff Michael C
Large shareholder
33,408 -9.7%
392.84
US$2,174,082 		33,408 -9.7% 392.84 US$2,174,082
2026-04-02 2026-03-31 B Purchase
Skaff Michael C
Large shareholder
23,740 +45.2%
454.97
US$1,565,783 		23,740 +45.2% 454.97 US$1,565,783
2023-06-20 2023-06-20 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
14,000 +19.3%
0.53
US$7,420 		14,000 +19.3% 0.53 US$7,420
2023-06-20 2023-06-16 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
5,000 +7.4%
0.53
US$2,650 		5,000 +7.4% 0.53 US$2,650
2023-06-20 2023-06-16 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
10,000 +17.4%
0.54
US$5,400 		10,000 +17.4% 0.54 US$5,400
2023-06-20 2023-06-15 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
21 +0.0%
0.50
US$10 		21 +0.0% 0.50 US$10
2023-06-15 2023-06-14 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
10,000 +21.1%
0.49
US$4,900 		10,000 +21.1% 0.49 US$4,900
2022-12-28 2022-12-23 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
20,000 +72.7%
0.50
US$10,000 		20,000 +72.7% 0.50 US$10,000
2022-06-03 2022-06-01 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
4,000 +17.0%
1.83
US$7,320 		4,000 +17.0% 1.83 US$7,320
2022-06-03 2022-05-31 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
8,000 +51.6%
2.03
US$16,240 		8,000 +51.6% 2.03 US$16,240
2021-05-25 2021-05-25 B Purchase
1.9
Amman Bradford K.

Chief Financial Officer

Officer
1,000 +100.0%
5.29
US$5,290 		1,000 +100.0% 5.29 US$5,290
2021-05-25 2021-05-25 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director
4,000 +266.7%
5.38
US$21,520 		4,000 +266.7% 5.38 US$21,520
2020-12-28 2020-12-24 B Purchase
1.9
Amman Bradford K.

Chief Financial Officer

Officer
1,000 +inf%
7.38
US$7,380 		1,000 +inf% 7.38 US$7,380
2020-12-23 2020-12-23 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
1,000 +200.0%
7.27
US$7,267 		1,000 +200.0% 7.27 US$7,267
2020-12-14 2020-12-11 B Purchase
2.1
Huntsman Ronald Kirk

Chief Executive Officer

Executive Director Large shareholder
500 +inf%
8.50
US$4,250 		500 +inf% 8.50 US$4,250
Explore more

More insider trading research around Vivos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America